143 related articles for article (PubMed ID: 25834499)
1. Vancomycin-resistant enterococci colonization in patients with hematological malignancies: screening and its cost-effectiveness.
Gedik H; Şimşek F; Kantürk A; Yıldırmak T; Arıca D; Aydın D; Yokuş O; Demirel N
Afr Health Sci; 2014 Dec; 14(4):899-905. PubMed ID: 25834499
[TBL] [Abstract][Full Text] [Related]
2. Vancomycin-resistant enterococci colonization and bacteremia in patients with hematological malignancies.
Gedik H; Yıldırmak T; Simşek F; Kantürk A; Arıca D; Aydın D; Yokuş O; Demirel N; Arabacı C
J Infect Dev Ctries; 2014 Sep; 8(9):1113-8. PubMed ID: 25212075
[TBL] [Abstract][Full Text] [Related]
3. Hypogammaglobulinemia and Poor Performance Status are Predisposing Factors for Vancomycin-Resistant Enterococcus Colonization in Patients with Hematological Malignancies.
Ümit EG; Kuloğlu F; Demir AM
Turk J Haematol; 2017 Mar; 34(1):89-92. PubMed ID: 27531123
[TBL] [Abstract][Full Text] [Related]
4. Vancomycin-resistant enterococci colonization among dialysis patients: a meta-analysis of prevalence, risk factors, and significance.
Zacharioudakis IM; Zervou FN; Ziakas PD; Rice LB; Mylonakis E
Am J Kidney Dis; 2015 Jan; 65(1):88-97. PubMed ID: 25042816
[TBL] [Abstract][Full Text] [Related]
5. The outcome of non-carbapenem-based empirical antibacterial therapy and VRE colonisation in patients with hematological malignancies.
Gedik H; Yildirmak T; Simsek F; Kanturk A; Aydýn D; Anca D; Yokus O; Demirel N
Afr Health Sci; 2013 Jun; 13(2):362-8. PubMed ID: 24235937
[TBL] [Abstract][Full Text] [Related]
6. Is it worth screening for vancomycin-resistant Enterococcus faecium colonization?: Financial burden of screening in a developing country.
Ulu-Kilic A; Özhan E; Altun D; Perçin D; Güneş T; Alp E
Am J Infect Control; 2016 Apr; 44(4):e45-9. PubMed ID: 26775930
[TBL] [Abstract][Full Text] [Related]
7. Prediction of Bloodstream Infection Due to Vancomycin-Resistant Enterococcus in Patients Undergoing Leukemia Induction or Hematopoietic Stem-Cell Transplantation.
Webb BJ; Healy R; Majers J; Burr Z; Gazdik M; Lopansri B; Hoda D; Petersen FB; Ford C
Clin Infect Dis; 2017 Jun; 64(12):1753-1759. PubMed ID: 28369204
[TBL] [Abstract][Full Text] [Related]
8. Molecular epidemiology and risk factors for colonization by vancomycin-resistant Enterococcus in patients with hematologic malignancies.
Almyroudis NG; Lesse AJ; Hahn T; Samonis G; Hazamy PA; Wongkittiroch K; Wang ES; McCarthy PL; Wetzler M; Segal BH
Infect Control Hosp Epidemiol; 2011 May; 32(5):490-6. PubMed ID: 21515980
[TBL] [Abstract][Full Text] [Related]
9. Vancomycin-resistant Enterococcus colonization and bloodstream infection: prevalence, risk factors, and the impact on early outcomes after allogeneic hematopoietic cell transplantation in patients with acute myeloid leukemia.
Hefazi M; Damlaj M; Alkhateeb HB; Partain DK; Patel R; Razonable RR; Gastineau DA; Al-Kali A; Hashmi SK; Hogan WJ; Litzow MR; Patnaik MM
Transpl Infect Dis; 2016 Dec; 18(6):913-920. PubMed ID: 27642723
[TBL] [Abstract][Full Text] [Related]
10. Discontinuation of Systematic Surveillance and Contact Precautions for Vancomycin-Resistant Enterococcus (VRE) and Its Impact on the Incidence of VRE faecium Bacteremia in Patients with Hematologic Malignancies.
Almyroudis NG; Osawa R; Samonis G; Wetzler M; Wang ES; McCarthy PL; Segal BH
Infect Control Hosp Epidemiol; 2016 Apr; 37(4):398-403. PubMed ID: 26750087
[TBL] [Abstract][Full Text] [Related]
11. Decrease in Vancomycin-Resistant Enterococcus Colonization After Extensive Renovation of a Unit Dedicated to the Treatment of Hematologic Malignancies and Hematopoietic Stem-Cell Transplantation.
Ford CD; Gazdik Stofer MA; Coombs J; Lopansri BK; Webb BJ; Motyckova G; Petersen FB
Infect Control Hosp Epidemiol; 2017 Sep; 38(9):1055-1061. PubMed ID: 28724453
[TBL] [Abstract][Full Text] [Related]
12. Vancomycin use in surrounding patients during critical illness and risk for persistent colonization with vancomycin-resistant Enterococcus.
Zachariah P; Freedberg DE
J Hosp Infect; 2019 Jul; 102(3):343-346. PubMed ID: 30641098
[TBL] [Abstract][Full Text] [Related]
13. The local hospital milieu and healthcare-associated vancomycin-resistant enterococcus acquisition.
Zhou MJ; Li J; Salmasian H; Zachariah P; Yang YX; Freedberg DE
J Hosp Infect; 2019 Jan; 101(1):69-75. PubMed ID: 30026006
[TBL] [Abstract][Full Text] [Related]
14. Results of Four-Year Rectal Vancomycin-Resistant Enterococci Surveillance in a Pediatric Hematology-Oncology Ward: From Colonization to Infection.
Aktürk H; Sütçü M; Somer A; Karaman S; Acar M; Ünüvar A; Anak S; Karakaş Z; Özdemir A; Sarsar K; Aydın D; Salman N
Turk J Haematol; 2016 Sep; 33(3):244-7. PubMed ID: 27094847
[TBL] [Abstract][Full Text] [Related]
15. Vancomycin-resistant enterococci infection and predisposing factors for infection and mortality in patients with acute leukaemia and febrile neutropenia.
Kirkizlar TA; Akalin H; Kirkizlar O; Ozkalemkas F; Ozkocaman V; Kazak E; Ozakin C; Bulbul EN; Ozboz ES; Ali R
Leuk Res; 2020 Dec; 99():106463. PubMed ID: 33130331
[TBL] [Abstract][Full Text] [Related]
16. Vancomycin resistant enterococcus risk factors for hospital colonization in hematological patients: a matched case-control study.
Meschiari M; Kaleci S; Monte MD; Dessilani A; Santoro A; Scialpi F; Franceschini E; Orlando G; Cervo A; Monica M; Forghieri F; Venturelli C; Ricchizzi E; Chester J; Sarti M; Guaraldi G; Luppi M; Mussini C
Antimicrob Resist Infect Control; 2023 Nov; 12(1):126. PubMed ID: 37957773
[TBL] [Abstract][Full Text] [Related]
17. Incidence of vancomycin-resistant enterococci (VRE) infection in high-risk febrile neutropenic patients colonized with VRE.
Bossaer JB; Hall PD; Garrett-Mayer E
Support Care Cancer; 2010 Feb; 19(2):231-7. PubMed ID: 20069435
[TBL] [Abstract][Full Text] [Related]
18. Decrease in vancomycin-resistant Enterococcus colonization associated with a reduction in carbapenem use as empiric therapy for febrile neutropenia in patients with acute leukemia.
Ford CD; Coombs J; Stofer MG; Lopansri BK; Webb BJ; Ostronoff F; Asch J; Hoda D
Infect Control Hosp Epidemiol; 2019 Jul; 40(7):774-779. PubMed ID: 31046849
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of vancomycin-resistant enterococci (VRE)-associated morbidity following relaxation of VRE screening and isolation precautions in a tertiary care hospital.
Popiel KY; Miller MA
Infect Control Hosp Epidemiol; 2014 Jul; 35(7):818-25. PubMed ID: 24915209
[TBL] [Abstract][Full Text] [Related]
20. 10-year trends in vancomycin-resistant enterococci among allogeneic hematopoietic cell transplant recipients.
MacAllister TJ; Stohs E; Liu C; Bryan A; Whimbey E; Phipps A; Pergam SA
J Infect; 2018 Jul; 77(1):38-46. PubMed ID: 29746941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
